1. Lisnevskaia, L, Murphy, G, Isenberg, D. Systemic lupus erythematosus. The Lancet 2014; 384: 1878–1888.
Google Scholar | Crossref | Medline | ISI2. Bryant, VL, Ma, CS, Avery, DT, et al. Cytokine-mediated regulation of human B cell differentiation into Ig-secreting cells: predominant role of IL-21 produced by CXCR5+ T follicular helper cells. J Immunol 2007; 179: 8180–8190.
Google Scholar | Crossref | Medline | ISI3. Sawaf, M, Dumortier, H, Monneaux, F. Follicular helper t cells in systemic lupus erythematosus: why should they be considered as interesting therapeutic targets? J Immunology Research 2016; 2016: 5767106.
Google Scholar | Crossref | Medline4. Kim, SJ, Lee, K, Diamond, B. Follicular helper t cells in systemic lupus erythematosus. Front Immunology 2018; 9: 1793.
Google Scholar | Crossref | Medline5. Cannons, JL, Lu, KT, Schwartzberg, PL. T follicular helper cell diversity and plasticity. Trends Immunol 2013; 34: 200–207.
Google Scholar | Crossref | Medline6. Dolff, S, Abdulahad, WH, Westra, J, et al. Increase in IL-21 producing T-cells in patients with systemic lupus erythematosus. Arthritis Res Ther 2011; 13: R157.
Google Scholar | Crossref | Medline | ISI7. Petri, M, Stohl, W, Chatham, W, et al. Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus. Arthritis Rheum 2008; 58: 2453–2459.
Google Scholar | Crossref | Medline8. Paradowska-Gorycka, A, Wajda, A, Stypinska, B, et al. Variety of endosomal TLRs and Interferons (IFN-α, IFN-β, IFN-γ) expression profiles in patients with SLE, SSc and MCTD. Clin Exp Immunol 2021; 204: 49–63.
Google Scholar | Crossref | Medline9. Zhang, Q, Ding, S, Zhang, H, et al. Increased Set1 binding at the promoter induces aberrant epigenetic alterations and up-regulates cyclic adenosine 5′-monophosphate response element modulator alpha in systemic lupus erythematosus. Clin Epigenetics 2016; 8: 126.
Google Scholar | Crossref | Medline10. Vogelzang, A, McGuire, HM, Yu, D, et al. A fundamental role for interleukin-21 in the generation of T follicular helper cells. Immunity 2008; 29: 127–137.
Google Scholar | Crossref | Medline11. Ou, X, Xu, S, Lam, KP. Deficiency in TNFRSF13B (TACI) expands T-follicular helper and germinal center B cells via increased ICOS-ligand expression but impairs plasma cell survival. Proc Natl Acad Sci 2012; 109: 15401–15406.
Google Scholar | Crossref | Medline12. Goenka, R, Matthews, AH, Zhang, B, et al. Local BLyS production by T follicular cells mediates retention of high affinity B cells during affinity maturation. J Exp Med 2014; 211: 45–56.
Google Scholar | Crossref | Medline13. Navarra, SV, Guzmán, RM, Gallacher, AE, et al. Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial. The Lancet 2011; 377: 721–731.
Google Scholar | Crossref | Medline | ISI14. Hayashi, T . Therapeutic strategies for SLE involving cytokines: mechanism-oriented therapies especially IFN-gamma targeting gene therapy. J Biomedicine Biotechnology 2010; 2010.
Google Scholar | Crossref15. Dong, L, Ito, SI, Ishii, KJ, et al. Suppressive oligonucleotides protect against collagen-induced arthritis in mice. Arthritis Rheum 2004; 50: 1686–1689.
Google Scholar | Crossref | Medline16. Xu, WD, Zhang, YJ, Wang, W, et al. Role of CREM in systemic lupus erythematosus. Cell Immunol 2012; 276: 10–15.
Google Scholar | Crossref | Medline17. Rauen, T, Hedrich, CM, Juang, YT, et al. cAMP-responsive element modulator (crem)α protein induces interleukin 17a expression and mediates epigenetic alterations at the interleukin-17A gene locus in patients with systemic lupus erythematosus. J Biol Chem 2011; 286: 43437–43446.
Google Scholar | Crossref | Medline | ISI18. Crispín, JC, Tsokos, GC. IL-17 in systemic lupus erythematosus. J Biomed Biotechnol 2010; 2010: 943254.
Google Scholar | Crossref | Medline19. Alzabin, S, Bhardwaj, N, Kiefer, F, et al. Hematopoietic progenitor kinase 1 is a negative regulator of dendritic cell activation. J Immunol 2009; 182: 6187–6194.
Google Scholar | Crossref | Medline20. Arnold, R, Liou, J, Drexler, HCA, et al. Caspase-mediated cleavage of hematopoietic progenitor kinase 1 (hpk1) converts an activator of NFΚB into an inhibitor of NFκB. J Biol Chem 2001; 276: 14675–14684.
Google Scholar | Crossref | Medline21. Arnold, R, Patzak, IM, Neuhaus, B, et al. Activation of hematopoietic progenitor kinase 1 involves relocation, autophosphorylation, and transphosphorylation by protein kinase D1. Mol Cell Biol 2005; 25: 2364–2383.
Google Scholar | Crossref | Medline22. Wang, H, Song, X, Logsdon, C, et al. Proteasome-mediated degradation and functions of hematopoietic progenitor kinase 1 in pancreatic cancer. Cancer Res 2009; 69: 1063–1070.
Google Scholar | Crossref | Medline23. Alzabin, S, Pyarajan, S, Yee, H, et al. Hematopoietic progenitor kinase 1 is a critical component of prostaglandin E2-mediated suppression of the anti-tumor immune response. Cancer Immunol Immunother 2010; 59: 419–429.
Google Scholar | Crossref | Medline24. Shui, JW, Boomer, JS, Han, J, et al. Hematopoietic progenitor kinase 1 negatively regulates T cell receptor signaling and T cell-mediated immune responses. Nat Immunol 2007; 8: 84–91.
Google Scholar | Crossref | Medline25. Zhang, Q, Long, H, Liao, J, et al. Inhibited expression of hematopoietic progenitor kinase 1 associated with loss of jumonji domain containing 3 promoter binding contributes to autoimmunity in systemic lupus erythematosus. J Autoimmun 2011; 37: 180–189.
Google Scholar | Crossref | Medline26. Tan, EM, Cohen, AS, Fries, JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271–1277.
Google Scholar | Crossref | Medline27. Bombardier, C, Gladman, DD, Urowitz, MB, et al. Derivation of the sledai. A disease activity index for lupus patients. Arthritis Rheum 1992; 35: 630–640.
Google Scholar | Crossref | Medline28. Gladman, D, Ginzler, E, Goldsmith, C, et al.The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996; 39: 363–369.
Google Scholar | Crossref | Medline29. Craft, JE . Follicular helper T cells in immunity and systemic autoimmunity. Nat Rev Rheumatol 2012; 8: 337–347.
Google Scholar | Crossref | Medline | ISI30. Ma, CS, Deenick, EK, Batten, M, et al. The origins, function, and regulation of T follicular helper cells. J Exp Med 2012; 209: 1241–1253.
Google Scholar | Crossref | Medline | ISI31. Crotty, S . T follicular helper cell differentiation, function, and roles in disease. Immunity 2014; 41: 529–542.
Google Scholar | Crossref | Medline | ISI32. Ueno, H, Banchereau, J, Vinuesa, CG. Pathophysiology of T follicular helper cells in humans and mice. Nat Immunol 2015; 16: 142–152.
Google Scholar | Crossref | Medline | ISI33. Schulze-Luehrmann, J, Santner-Nanan, B, Jha, MK, et a. Hematopoietic progenitor kinase 1 supports apoptosis of T lymphocytes. Blood 2002; 100: 954–960.
Google Scholar | Crossref | Medline34. Chen, YR, Meyer, CF, Ahmed, B, et al. Caspase-mediated cleavage and functional changes of hematopoietic progenitor kinase 1 (HPK1). Oncogene 1999; 18: 7370–7377.
Google Scholar | Crossref | Medline35. Brenner, D, Golks, A, Becker, M, et al. Caspase-cleaved HPK1 induces CD95L-independent activation-induced cell death in T and B lymphocytes. Blood 2007; 110: 3968–3977.
Google Scholar | Crossref | Medline36. Hu, MCT, Wang, YP, Qiu, WR, et al. Hematopoietic progenitor kinase-1 (HPK1) stress response signaling pathway activates IκB kinases (IKK-α/β) and IKK-β is a developmentally regulated protein kinase. Oncogene 1999; 18: 5514–5524.
Google Scholar | Crossref | Medline37. Brenner, D, Krammer, PH, Arnold, R. Concepts of activated T cell death. Crit Rev Oncology/Hematology 2008; 66: 52–64.
Google Scholar | Crossref | Medline38. Krammer, PH, Arnold, R, Lavrik, IN. Life and death in peripheral T cells. Nat Rev Immunol 2007; 7: 532–542.
Google Scholar | Crossref | Medline | ISI39. Acuto, O, Bartolo, VD, Michel, F. Tailoring T-cell receptor signals by proximal negative feedback mechanisms. Nat Rev Immunol 2008; 8: 699–712.
Google Scholar | Crossref | Medline40. Bartolo, VD, Montagne, B, Salek, M, et al. A novel pathway down-modulating T cell activation involves HPK-1-dependent recruitment of 14-3-3 proteins on SLP-76. J Exp Med 2007; 204: 681–691.
Google Scholar | Crossref | Medline41. Patzak, IM, Königsberger, S, Suzuki, A, et al. HPK1 competes with ADAP for SLP-76 binding and via Rap1 negatively affects T-cell adhesion. Eur J Immunol 2010; 40: 3220–3225.
Google Scholar | Crossref | Medline